| 5AJR: reference: Antiparasitic effect in vitro, activity in a murine model of Chagas disease, and structural characterization in complex with the target enzyme CYP51 from Trypanosoma cruzi of the potent clinical candidate VT-1161., Hoekstra WJ, Hargrove TY, Wawrzak Z, Batista DD, da Silva CF, Nefertiti AS, Rachakonda G, Schotzinger RJ, Villalta F, Soeiro MN, Lepesheva GI, Antimicrob Agents Chemother. 2015 Dec 7. pii: AAC.02287-15. PMID: 26643331 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).